Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sweatcoin’s digital health platform has demonstrated significant impact in clinical settings, notably in NHS-backed diabetes prevention trials. Participants using the app increased daily step counts by an average of 45%, lost an average of 3kg over a 10-week program, and showed high retention rates (~92%). One in ten participants lost at least 10% of their body weight. The approach has been recognized as a breakthrough for scalable lifestyle interventions targeting chronic disease risk.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sweatcoin.